Article Details
Retrieved on: 2020-11-30 12:06:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company starts out with $40 million from 5AM Ventures, <b>Atlas Venture</b> and Gimv that will push the program, KN-002, into the clinic next year.
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here